PNC Financial Services Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281 | Buy |
+15
| New | +$281 | ﹤0.01% | 4768 |
|
|
2024
Q3 | – | Sell |
-1,034
| Closed | -$8.5K | – | 4898 |
|
|
2024
Q2 | $8.5K | Buy |
1,034
+34
| +3% | +$279 | ﹤0.01% | 3830 |
|
|
2024
Q1 | $14.8K | Sell |
1,000
-100
| -9% | -$1.48K | ﹤0.01% | 3592 |
|
|
2023
Q4 | $16K | Hold |
1,100
| – | – | ﹤0.01% | 3558 |
|
|
2023
Q3 | $11.9K | Buy |
1,100
+100
| +10% | +$1.08K | ﹤0.01% | 3675 |
|
|
2023
Q2 | $12.9K | Hold |
1,000
| – | – | ﹤0.01% | 3757 |
|
|
2023
Q1 | $13.2K | Hold |
1,000
| – | – | ﹤0.01% | 3686 |
|
|
2022
Q4 | $15K | Hold |
1,000
| – | – | ﹤0.01% | 3610 |
|
|
2022
Q3 | $12K | Sell |
1,000
-65
| -6% | -$780 | ﹤0.01% | 3676 |
|
|
2022
Q2 | $11K | Hold |
1,065
| – | – | ﹤0.01% | 3778 |
|
|
2022
Q1 | $32K | Hold |
1,065
| – | – | ﹤0.01% | 3347 |
|
|
2021
Q4 | $29K | Hold |
1,065
| – | – | ﹤0.01% | 3386 |
|
|
2021
Q3 | $38K | Buy |
1,065
+65
| +7% | +$2.32K | ﹤0.01% | 3222 |
|
|
2021
Q2 | $43K | Hold |
1,000
| – | – | ﹤0.01% | 3150 |
|
|
2021
Q1 | $34K | Hold |
1,000
| – | – | ﹤0.01% | 3183 |
|
|
2020
Q4 | $35K | Buy |
+1,000
| New | +$35K | ﹤0.01% | 3102 |
|
|
2016
Q3 | – | Sell |
-75
| Closed | -$2K | – | 4225 |
|
|
2016
Q2 | $2K | Sell |
75
-2
| -3% | -$53 | ﹤0.01% | 4208 |
|
|
2016
Q1 | $2K | Buy |
77
+2
| +3% | +$52 | ﹤0.01% | 4208 |
|
|
2015
Q4 | $2K | Sell |
75
-600
| -89% | -$16K | ﹤0.01% | 4192 |
|
|
2015
Q3 | $16K | Sell |
675
-1,197
| -64% | -$28.4K | ﹤0.01% | 3476 |
|
|
2015
Q2 | $60K | Buy |
1,872
+72
| +4% | +$2.31K | ﹤0.01% | 2929 |
|
|
2015
Q1 | $64K | Hold |
1,800
| – | – | ﹤0.01% | 2916 |
|
|
2014
Q4 | $40K | Hold |
1,800
| – | – | ﹤0.01% | 2882 |
|
|
2014
Q3 | $34K | Buy |
+1,800
| New | +$34K | ﹤0.01% | 2857 |
|